amphiregulin (schwannoma-derived growth factor) (AREG)
|
167.6 (Down)
|
131.25 (down)
|
3.74 (down)
|
transforming growth factor, alpha (TGFA)
|
57.21 (down)
|
28.49 (down)
|
|
fibroblast growth factor binding protein 1 (FGFBP1)
|
38.75 (down)
|
23.011 (down)
|
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (FLT1)
|
31.0 (up)
|
|
96.42 (down)
|
Platelet derived growth factor receptor alpha (PDGFRA)
|
26.10 (up)
|
33.93 (up)
|
|
platelet-derived growth factor receptor, beta polypeptide (PDGFRB)
|
20.52 (up)
|
21.90 (up)
|
|
insulin-like growth factor binding protein 5 (IGFBP5)
|
17.65 (up)
|
14.81 (up)
|
|
growth factor receptor-bound protein 14 (GRB14)
|
17.23 (down)
|
5.82 (down)
|
2.95 (down)
|
fibroblast growth factor 2 (basic) (FGF2)
|
13.78 (up)
|
|
|
fibroblast growth factor 11 (FGF11)
|
12.83 (down)
|
|
|
keratinocyte growth factor-like protein 1 (KGFLP1)
|
10.9 (up)
|
|
9.85 (up)
|
fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) (FGFR1)
|
10.50 (up)
|
8.96 (up)
|
|
insulin-like growth factor 2 (somatomedin A) (IGF2)
|
9.9 (up)
|
6.2 (up)
|
|
connective tissue growth factor (CTGF)
|
9.77 (up)
|
15.45 (up)
|
2.3 (up)
|
pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) (PTN)
|
8.54 (up)
|
9.9 (up)
|
|
insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1)
|
8.10 (up)
|
|
|
fibroblast growth factor 1 (acidic) (FGF1)
|
8.03 (up)
|
5.41 (up)
|
7.41 (down)
|
Insulin-like growth factor binding protein 4 (IGFBP4)
|
7.65 (up)
|
14.2 (up)
|
2.96 (up)
|
fibroblast growth factor 7 (keratinocyte growth factor) (FGF7)
|
7.51 (up)
|
15 (up)
|
4.51 (up)
|
platelet derived growth factor D (PDGFD)
|
5.97 (up)
|
12.7 (up)
|
|
fibroblast growth factor binding protein 3 (FGFBP3)
|
5.68 (up)
|
4.4 (up)
|
|
insulin-like growth factor binding protein 5 (IGFBP5)
|
5.61 (up)
|
5.4 (up)
|
2.95 (down)
|
fibroblast growth factor receptor 2 (fgfr2)
|
4.50 (down)
|
|
4.89 (up)
|
Hepatocyte growth factor precursor (Scatter factor) (SF) (Hepatopoeitin-A)
|
4.05 (up)
|
10.06 (up)
|
|
transforming growth factor beta 1 induced transcript 1 (TGFB1I1), transcript variant 2
|
3.94 (up)
|
2.97 (up)
|
|
nerve growth factor, beta polypeptide (NGFB)
|
3.83 (up)
|
|
2.6 (down)
|
chemokine (C-X-C motif) ligand 2 (CXCL2)
|
79.06 (down)
|
4.5 (down)
|
|
chemokine (C-X-C motif) ligand 3 (CXCL3)
|
26.25 (down)
|
16.0 (down)
|
3.88 (up)
|
chemokine (C-X-C motif) ligand 1 (CXCL1)
|
65.87 (down)
|
64.9 (down)
|
|
chemokine (C-X-C motif) ligand 11 (CXCL11)
|
58.344 (down)
|
14.42 (down)
|
|
chemokine (C-X-C motif) ligand 10 (CXCL10)
|
7.71 (down)
|
6.97 (down)
|
|
chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) (CXCL12)
|
34.26 (up)
|
82.68 (up)
|
|
chemokine (C-C motif) ligand 26 (CCL26)
|
11.4 (up)
|
2.49 (up)
|
|
chemokine (C-C motif) ligand 2 (CCL2)
|
23.43 (up)
|
|
3.48 (down)
|
chemokine (C-C motif) ligand 13 (CCL13)
|
12.42 (up)
|
|
2.34 (up)
|
interleukin 1, alpha (IL1A)
|
78.72 (down)
|
63.61 (down)
|
|
interleukin 1, beta (IL1B)
|
48.57 (down)
|
28.89 (down)
|
|
interleukin 1 receptor, type II (IL1R2)
|
12.17 (down)
|
21.03 (down)
|
3.92 (up)
|
interleukin 1 receptor antagonist (IL1RN)
|
20.06 (down)
|
15.10 (down)
|
|
interleukin 20 receptor, alpha (IL20RA)
|
210.69 (down)
|
|
|
interleukin 18 (interferon-gamma-inducing factor) (IL18)
|
78.26 (down)
|
56.72 (down)
|
|
interleukin 23, alpha subunit p19 (IL23A)
|
28.40 (down)
|
29.29 (down)
|
|
interleukin 11 receptor, alpha (IL11RA)
|
15.58 (up)
|
|
|
neurotrophin 5 (NTF5)
|
14.96 (down)
|
11.64 (up)
|
|
neurotrophin 3 (NTF3)
|
16.40 (up)
|
7.50 (up)
|
7.48 (down)
|
nerve growth factor, beta polypeptide (NGFB)
|
3.8 (up)
|
|
|
Glial cell line-derived neurotrophic factor precursor (Astrocyte- derived trophic factor 1)
|
4.24 (up)
|
6.56 (up)
|
|
GDNF family receptor alpha 1 (GFRA1)
|
6.5 (up)
|
6.28 (up)
|
|
| brain-derived neurotrophic factor (BDNF) |
9.15 (up) |
3.69 (up) |
8.68 (down) |
